WORK to Save Lives Act
Sponsored By: Senator Jeff Merkley
Introduced
Summary
Pushes workplaces to make opioid overdose reversal medication and annual employee training widely available. This bill would direct OSHA to issue nonbinding guidance for private employers and require Federal agencies to adopt binding rules on the same topics within 270 days.
Show full summary
- Private employers: OSHA would publish nonmandatory guidance within 270 days on acquiring and maintaining opioid overdose reversal medication and on training employees annually.
- Federal agencies and employees: Federal agencies would be required to acquire and maintain opioid overdose reversal medication and to provide annual training for staff. The Veterans Health Administration is explicitly included.
- United States Postal Service: The bill excludes the USPS from the private employer guidance so USPS workplaces would not be covered by that nonbinding guidance.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Guidance for private employers on overdose kits
This bill would direct the Labor Secretary, through OSHA, to publish nonmandatory guidance for private employers within 270 days after enactment. The guidance would advise how to acquire and maintain opioid overdose reversal medication and how to train employees each year to use it. The bill would use OSHA's usual definition of “employer” but would exclude the United States Postal Service. The guidance would be voluntary and would not itself impose binding duties on private employers.
Overdose kits required in federal workplaces
This bill would require the Labor Secretary, through OSHA, to issue regulations within 270 days after enactment that require each Federal agency to acquire and maintain opioid overdose reversal medication and to train employees annually on its use. The rule would apply to any agency or instrumentality of the Federal Government and would specifically include the Veterans Health Administration, notwithstanding 38 U.S.C. 7425(b). These requirements would be binding on federal agencies.
Sponsors & CoSponsors
Sponsor
Jeff Merkley
OR • D
Cosponsors
Lisa Murkowski
AK • R
Sponsored 2/10/2026
Martin Heinrich
NM • D
Sponsored 2/10/2026
Adam Schiff
CA • D
Sponsored 2/10/2026
Ron Wyden
OR • D
Sponsored 2/10/2026
Angela Alsobrooks
MD • D
Sponsored 3/10/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in